Prasugrel Outshines Rival Drugs After Invasive Coronary Care
Among commonly used antiplatelet agents, prasugrel offers the most optimal balance between efficacy and safety after invasive management of patients with coronary syndrome, a meta-analysis finds. Medscape Medical News source https://www.medscape.com/viewarticle/prasugrel-outshines-rival-drugs-after-invasive-coronary-care-2026a1000i8y?src=rss